tiprankstipranks
JW Pharmaceutical Corporation (KR:001060)
:001060
South Korea Market
001060
JW Pharmaceutical Corporation
RESEARCH TOOLSreports

JW Pharmaceutical Corporation (001060) Ratios

― Followers

JW Pharmaceutical Corporation Ratios

KR:001060's free cash flow for Q2 2026 was ₩0.47. For the 2026 fiscal year, KR:001060's free cash flow was decreased by ₩ and operating cash flow was ₩0.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.56 1.42 1.47 1.32 1.12
Quick Ratio
 1.06 0.89 0.93 0.95 0.83
Cash Ratio
 0.20 0.19 0.05 0.06 0.09
Solvency Ratio
 0.48 0.34 0.31 0.16 0.12
Operating Cash Flow Ratio
 0.61 0.46 0.38 0.30 0.15
Short-Term Operating Cash Flow Coverage
 2.47 3.00 1.92 0.77 0.27
Net Current Asset Value
₩ 94.54B₩ 60.61B₩ 31.30B₩ -1.51B₩ 23.24B
Leverage Ratios
Debt-to-Assets Ratio
 0.11 0.09 0.15 0.26 0.33
Debt-to-Equity Ratio
 0.18 0.15 0.28 0.64 0.87
Debt-to-Capital Ratio
 0.15 0.13 0.22 0.39 0.47
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.07 0.10 <0.01
Financial Leverage Ratio
 1.61 1.64 1.83 2.43 2.61
Debt Service Coverage Ratio
 1.80 2.17 1.80 0.58 0.27
Interest Coverage Ratio
 14.93 19.86 8.22 7.69 6.71
Debt to Market Cap
 0.09 0.05 0.12 0.17 0.50
Interest Debt Per Share
 3.36K 2.45K 4.36K 7.43K 9.15K
Net Debt to EBITDA
 0.22 0.14 0.74 1.73 2.39
Profitability Margins
Gross Profit Margin
47.32%46.38%44.97%44.84%42.08%
EBIT Margin
12.95%11.34%12.66%8.92%8.22%
EBITDA Margin
15.33%13.76%15.31%11.92%10.73%
Operating Profit Margin
13.95%11.34%11.47%12.91%9.20%
Pretax Profit Margin
14.06%11.47%11.46%7.33%6.63%
Net Profit Margin
12.35%7.96%9.04%4.94%4.66%
Continuous Operations Profit Margin
12.35%7.96%9.04%5.13%4.36%
Net Income Per EBT
87.84%69.44%78.91%67.48%70.30%
EBT Per EBIT
100.79%101.09%99.92%56.75%72.05%
Return on Assets (ROA)
15.35%10.19%10.76%5.74%5.08%
Return on Equity (ROE)
26.74%16.70%19.74%13.94%13.27%
Return on Capital Employed (ROCE)
26.04%22.18%20.83%26.98%25.40%
Return on Invested Capital (ROIC)
20.36%14.08%14.74%14.24%9.10%
Return on Tangible Assets
17.11%11.41%11.54%6.02%5.21%
Earnings Yield
16.27%10.02%11.62%4.33%7.61%
Efficiency Ratios
Receivables Turnover
 6.96 6.55 4.62 4.31 4.64
Payables Turnover
 3.58 7.45 6.64 5.59 4.78
Inventory Turnover
 3.87 3.79 3.54 3.89 3.55
Fixed Asset Turnover
 5.06 4.69 4.18 4.81 5.56
Asset Turnover
 1.24 1.28 1.19 1.16 1.09
Working Capital Turnover Ratio
 7.41 8.37 7.61 10.97 10.60
Cash Conversion Cycle
 44.57 103.10 127.09 113.17 105.16
Days of Sales Outstanding
 52.42 55.69 79.03 84.67 78.68
Days of Inventory Outstanding
 94.20 96.43 103.02 93.79 102.82
Days of Payables Outstanding
 102.04 49.02 54.96 65.29 76.34
Operating Cycle
 146.61 152.12 182.05 178.46 181.51
Cash Flow Ratios
Operating Cash Flow Per Share
 5.69K 3.99K 3.40K 3.54K 2.37K
Free Cash Flow Per Share
 4.83K 3.51K 2.20K 1.89K 1.86K
CapEx Per Share
 858.17 487.61 1.21K 1.65K 516.37
Free Cash Flow to Operating Cash Flow
 0.85 0.88 0.65 0.53 0.78
Dividend Paid and CapEx Coverage Ratio
 3.74 4.22 2.10 1.76 2.88
Capital Expenditure Coverage Ratio
 6.63 8.19 2.82 2.14 4.60
Operating Cash Flow Coverage Ratio
 1.87 1.76 0.87 0.51 0.27
Operating Cash Flow to Sales Ratio
 0.16 0.12 0.11 0.12 0.08
Free Cash Flow Yield
18.77%13.75%9.16%5.43%10.60%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 6.34 10.06 9.08 23.10 13.14
Price-to-Sales (P/S) Ratio
 0.75 0.79 0.78 1.14 0.61
Price-to-Book (P/B) Ratio
 1.53 1.67 1.70 3.22 1.74
Price-to-Free Cash Flow (P/FCF) Ratio
 5.38 7.27 10.92 18.41 9.43
Price-to-Operating Cash Flow Ratio
 4.67 6.39 7.05 9.81 7.38
Price-to-Earnings Growth (PEG) Ratio
 0.06 -2.42 0.11 1.84 >-0.01
Price-to-Fair Value
 1.53 1.67 1.70 3.22 1.74
Enterprise Value Multiple
 5.10 5.92 5.82 11.31 8.09
Enterprise Value
 636.12B 631.02B 641.10B 1.01T 594.61B
EV to EBITDA
 5.06 5.92 5.82 11.31 8.09
EV to Sales
 0.78 0.81 0.89 1.35 0.87
EV to Free Cash Flow
 5.57 7.46 12.51 21.73 13.39
EV to Operating Cash Flow
 4.73 6.55 8.08 11.58 10.48
Tangible Book Value Per Share
 14.47K 12.63K 12.38K 9.55K 8.76K
Shareholders’ Equity Per Share
 17.35K 15.30K 14.13K 10.79K 10.05K
Tax and Other Ratios
Effective Tax Rate
 0.12 0.31 0.21 0.30 0.34
Revenue Per Share
 34.72K 32.09K 30.84K 30.42K 28.61K
Net Income Per Share
 4.29K 2.56K 2.79K 1.50K 1.33K
Tax Burden
 0.88 0.69 0.79 0.67 0.70
Interest Burden
 1.09 1.01 0.91 0.82 0.81
Research & Development to Revenue
 0.04 0.06 0.05 0.04 0.05
SG&A to Revenue
 0.23 0.22 0.22 0.20 0.19
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.38 1.65 1.22 2.48 1.90
Currency in KRW